glp-1 lean mass loss agonists and changes in body and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Balancing weight and muscle loss

More practical contributors to heart rate increases, especially early in therapy, may include volume depletion from gastrointestinal side effects such as nausea, vomiting, and diarrhea, which are common during GLP-1 receptor agonist initiation

Some research suggests this frequency maintains effectiveness for many applications

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS Semaglutide and Tirzepatide have been a source of disruption in the overall healthcare market

Such an imbalance of the good bacteria and bad bacteria in your digestive system can contribute to digestive conditions like IBS, of which bloating is a primary symptom 1 3

Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: Post-hoc analysis of a randomised, placebo-controlled phase II clinical trial